+(1).png)
(TheNewswire)
 | |||||||||
 | |||||||||
Edmonton, Alberta - TheNewswire - Oct. 11, 2023 - Innovotech Inc. (TSX-V:IOT) the “Company”) concluded its annual general and special meeting of shareholders on 10 October 2023. Shareholders voted in favor of all matters, which included the re-election of James Timourian, Karen Farkas, David Tam, Bernard Grobbelaar, Julie Wright, and Craig Milne as directors of the Company. Shareholders approved a grant of 150,000 incentive stock options under its stock option plan exercisable at $0.12 per share to six directors in the amount of 25,000 per director. The options are for five years and expire on October 12, 2028.
Shareholders also approved the appointment of D&H Group LLP as the Company auditors for the 2024 fiscal year and re-approval of the Company’s existing 10% rolling stock option plan.
About Innovotech:
Innovotech is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology. Innovotech can be found online at www.innovotech.ca.
Craig Milne, CEO & Director, Innovotech Inc. 1-604-239-1819 craig.milne@innovotech.ca
Copyright (c) 2023 TheNewswire - All rights reserved.
